People · Operator
Named in public records as an officer, director or promoter · active 2010–2017 · Other Health Care, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cytrellis Biosystems, Inc. | — | Other Health Care | Series C | $82.7M | $182.1M | 2012 |
| Seventh Sense Biosystems, Inc. | — | Biotechnology | Series B | $62.9M | $732.6M | 2010 |
| Accure Acne, Inc. | — | Other Health Care | Series B | $28.9M | $214.6M | 2017 |
R. ROX ANDERSON at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside R. ROX ANDERSON on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Langer | 1 | 36 |
| Alan Crane | 1 | 9 |
| Doug Cole | 1 | 6 |
| Harry Wilcox | 1 | 6 |
| Diane Marcou | 1 | 5 |
| John McDonough | 1 | 5 |
| NEIL EXTER | 1 | 5 |
| Timothy Richards | 1 | 4 |
| Michael L Peterson | 1 | 4 |
| PETER HUTT | 1 | 4 |
| Keith L. Crandell | 1 | 3 |
| HOWARD WEISMAN | 1 | 3 |
| HOWARD BERNSTEIN | 1 | 2 |
| Samuel E. Navarro | 1 | 2 |
| Milan Kofol | 1 | 2 |
| John A. McDonough | 1 | 2 |
| DOUG LEVINSON | 1 | 2 |
| AMY SIEGEL | 1 | 2 |
| Keith A. Crandall | 1 | 2 |
| Christopher Carlton | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.